PARTNERS IN GROWTH

Private Equity

We partner with exceptional innovative entrepreneurs and proven management teams to build global leaders in high growth sectors of the future.

Identifying Opportunities

Deep Sectoral Expertise

Gulf Capital’s Private Equity investment strategy is driven by a disciplined thematic approach. We focus on the sectors and sub-sectors of future growth through rigorous and continuous mapping and assessment of the investment landscape. Our senior sector aligned investment team is supported by a network of highly experienced advisors with decades of deep industry experience across their respective sectors. We bring a wealth of experience and strategic guidance to our management teams which helps our portfolio companies grow into leaders in their industries on the regional and international stage.

LOCAL TO GLOBAL

Cross Border Expansion

We are proud of our successful track record of building global leaders. We help our management teams identify opportunities to grow across borders and regions through organic and inorganic expansion into new markets. By building cross border champions, our businesses often catch the attention of regional strategic investors seeking value across both emerging and developed markets.

HANDS-ON OPERATIONAL APPROACH

Transformational Growth

We steer our businesses to accelerate growth through a focus on operational value creation. Our transformational growth team use a combination of financial, strategic, and operational levers to identify key growth drivers to clearly define a path to optimal performance. As hands-on partners, we collaborate closely with our management teams to navigate challenges and drive value together.

Our Portfolio

Sample Investments

Geidea

In May 2018, GC acquired a strategic stake in Geidea, the largest fintech company in Saudi Arabia by market share. Geidea recently became the only non-bank institution in Saudi Arabia to be granted an acquiring license from Saudi Central Bank (SAMA). The license enables Geidea to process secure, fast and seamless end-to-end payment solutions directly to merchants. Geidea is the first fintech in the region to develop an app based contactless ‘Tap on Phone’ solution which will empower SMEs with a simple and intuitive way to process customer payments.

ART Fertility Clinics

In January 2020, GC acquired a controlling stake in ART Fertility Clinics; the transaction is a corporate carve-out of the Middle Eastern clinics of IVI-RMA. ART Fertility Clinics is now an independent and leading provider of fertility treatments with the highest success rates internationally (69% Pregnancy rate). Having achieved over 5500+ pregnancies in less than five years, ART Fertility Clinics’ success is driven by the scientific and personalised approach of its highly skilled team.

Accumed

In February 2018, GC acquired a majority stake in ACCUMED, the leading RCM provider in the UAE and Saudi Arabia. In line with GC’s buy-and-build strategy and transforming businesses into global champions, the firm acquired Eclat Health a Washington DC-based technology-enabled healthcare solutions provider, and Hansei Solutions a tech-driven full-suite RCM operator based out of California. The acquisitions aim to establish a unique global platform with a comprehensive suite of RCM solutions for the entire health provider value chain.

Geidea

In Feb 2019, GC acquired a strategic stake in Geidea, the largest fintech company in Saudi Arabia by market share. Geidea recently became the only non-bank institution in Saudi Arabia to be granted an acquiring license from Saudi Central Bank (SAMA). The license enables Geidea to process secure, fast and seamless end-to-end payment solutions directly to merchants. Geidea is the first fintech in the region to develop an app based contactless ‘Tap on Phone’ solution which will empower SMEs with a simple and intuitive way to process customer payments.

ART Fertility Clinics

In January 2020, GC acquired a controlling stake in ART Fertility Clinics; the transaction is a corporate carve-out of the Middle Eastern clinics of IVI-RMA. ART Fertility Clinics is now an independent and leading provider of fertility treatments with the highest success rates internationally (69% Pregnancy rate). Having achieved over 5500+ pregnancies in less than five years, ART Fertility Clinics’ success is driven by the scientific and personalised approach of its highly skilled team. ART has operations in Oman and India.

Accumed

In February 2018, GC acquired a majority stake in ACCUMED, the leading RCM provider in the UAE and Saudi Arabia. In line with GC’s buy-and-build strategy and transforming businesses into global champions, the firm acquired Eclat Health a Washington DC-based technology-enabled healthcare solutions provider, and Hansei Solutions a tech-driven full-suite RCM operator based out of California. The acquisitions aim to establish a unique global platform with a comprehensive suite of RCM solutions for the entire healthcare provider value chain.

Vezeeta

Vezeeta is the leading digital healthcare technology platform in MEA. They are pioneering the shift to automated physician, clinic and hospital bookings, telehealth and e-pharmacy, making healthcare easily accessible and more efficient in the region. Vezeeta is transforming the healthcare experience of millions of patients across the MEA region, by digitally streamlining their journey, and ensuring easy access to quality care for all via AI-powered solutions.

Geidea

In May 2018, GC acquired a strategic stake in Geidea, the largest fintech company in Saudi Arabia by market share. Geidea recently became the only non-bank institution in Saudi Arabia to be granted an acquiring license from Saudi Central Bank (SAMA). The license enables Geidea to process secure, fast and seamless end-to-end payment solutions directly to merchants. Geidea is the first fintech in the region to develop an app based contactless ‘Tap on Phone’ solution which will empower SMEs with a simple and intuitive way to process customer payments.

ART Fertility Clinics

In January 2020, GC acquired a controlling stake in ART Fertility Clinics; the transaction is a corporate carve-out of the Middle Eastern clinics of IVI-RMA. ART Fertility Clinics is now an independent and leading provider of fertility treatments with the highest success rates internationally (69% Pregnancy rate). Having achieved over 5500+ pregnancies in less than five years, ART Fertility Clinics’ success is driven by the scientific and personalised approach of its highly skilled team.

Accumed

In February 2018, GC acquired a majority stake in ACCUMED, the leading RCM provider in the UAE and Saudi Arabia. In line with GC’s buy-and-build strategy and transforming businesses into global champions, the firm acquired Eclat Health a Washington DC-based technology-enabled healthcare solutions provider, and Hansei Solutions a tech-driven full-suite RCM operator based out of California. The acquisitions aim to establish a unique global platform with a comprehensive suite of RCM solutions for the entire health provider value chain.

Vezeeta

In February 2020, Vezeeta is the leading digital healthcare technology platform in MEA. They are pioneering the shift to automated physician, clinic and hospital bookings, telehealth and e-pharmacy, making healthcare easily accessible and more efficient in the region. Vezeeta is transforming the healthcare experience of millions of patients across the MEA region, by digitally streamlining their journey, and ensuring easy access to quality care for all via AI-powered solutions.

CWB

In October 2020, GC acquired a majority stake in the CWB Group, a leading intellectual property services provider across the Middle East and North Africa (MENA). CWB provides Patent and Trademark services including counseling, clearing, filing, prosecution, maintenance and enforcement services to Fortune 500 companies across the MENA region. CWB's service offering also extends to anti-counterfeiting and commercialization of IP. CWB works with its clients to conceive and execute strategic solutions to manage, protect and enforce their Intellectual Property ("IP") through its seven offices and member firms in the Middle East and North Africa region. Some of the world's most notable brand owners trust CWB to manage and protect their IP portfolios in the MENA region.

Our Portfolio